We are very pleased to welcome Dr. Gabriele Bleckert in our team. Gabriele Bleckert will support our customers with her experience in the areas of statistical programming and biostatistics. We are looking forward to a great cooperation!
We have completely redesigned the Staburo homepage to better inform you about our services. The simplified navigation enables you to find your desired services faster, and with the modern design, reading the website on your smartphone or tablet has been improved. (more…)
Network meta-analyses (NMAs) are a methods, which allows indirect comparisons of several medications. Indirect comparisons play an important role in the assessment of the cost-benefit ratio of drugs.
(more…)
Biomarker play an important role in modern pharmaceutical development because they allow a treatment adjusted for the patient’s individual circumstances. Recommendation for specific therapies for example based on the patient’s very own gene mutation profile (keyword “Precision Medicine”) take the place of the predominant “one-size-fits-all” approach.
In clinical trials, a treatment’s efficiency and safety is measured and evaluated. In oncology, standards have been developed to enable the harmonization of study results. These criteria are used for efficiency (response of treatment) as well as for safety (e.g. to detect a progression in time) evaluation.
Recent Comments